Form EFFECT Artiva Biotherapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 18, 2024 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
- Firebird Opens the Region's Largest AI Factory and Announces Global Expansion
- Ethereum Price Prediction Eyes $2,000 but the Wallets Chasing Real Returns Already Moved to Pepeto
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share